Why the study?
Is the Cardiff Cardiac Ablation PROM (C-CAP) a valid, reliable, and responsive tool for measuring outcomes in patients undergoing catheter ablation for cardiac arrhythmias?
Is the Cardiff Cardiac Ablation PROM (C-CAP) a valid, reliable, and responsive tool for measuring outcomes in patients undergoing catheter ablation for cardiac arrhythmias?
The C-CAP questionnaire is a valid, reliable, and responsive patient-reported outcome measure for evaluating symptom change and impact in patients undergoing cardiac ablation.
Answers are grounded in this paper and cite their sources.
C-CAP may aid outcome monitoring after ablation; extends arrhythmia-specific PROM validation but leaves open randomized confirmation.
PURPOSE: To formally test and validate a patient-reported outcome measure (PROM) for patients with cardiac arrhythmias undergoing catheter ablation procedures in the UK [Cardiff Cardiac Ablation PROM (C-CAP)]. METHODS: A multicentre, prospective, observational cohort study with consecutive patient enrolment from three UK sites was conducted. Patients were sent C-CAP questionnaires before and after an ablation procedure. Pre-ablation C-CAP1 (17 items) comprised four domains: patient expectations; condition and symptoms; restricted activity and healthcare visits; medication and general health. Post-ablation C-CAP2 (19 items) comprised five domains including change in symptoms and procedural complications. Both questionnaires also included the generic EQ-5D-5L tool (EuroQol). Reliability, validity, and responsiveness measures were calculated. RESULTS: A total of 517 valid pre-ablation and 434 post-ablation responses were received; questionnaires showed good feasibility and item acceptability. Internal consistency was good (Cronbach's alpha >0.7) and test-retest reliability was acceptable for all scales. C-CAP scales showed high responsiveness (effect size >0.8). Patients improved significantly (p < 0.001) following ablation across all disease-specific and global scales. Minimal clinically important difference was calculated. Improvement beyond the smallest detectable change of 9 points (symptom severity scale), 3 points (frequency and duration of symptoms scale), and 8 points (impact on life scale) indicates an important change. Amendments to the C-CAP questionnaires were identified through the validation process and made to produce the final tools. CONCLUSIONS: The final C-CAP questionnaires are valid, reliable, and responsive tools for measuring symptom change, impact, and expectations in patients undergoing ablation for cardiac arrhythmias. C-CAP questionnaires provide a tool with disease-specific and generic domains to explore how cardiac ablation procedures in the UK impact upon patients' lives.
No takes yet. Share an insight, caveat, or question.
White et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: